by Jordana Choucair | Feb 1, 2022 | D.C. News
President Joe Biden is set to relaunch the “cancer moonshot” program, which focused on ending cancer through investments in research and treatment, on Wednesday. Biden led the program in the final year of the Obama administration and then, in 2017,...
by Jordana Choucair | Feb 1, 2022 | Life Sciences
The Department of Justice (DOJ) announced that Cardinal Health will pay $13.1 million to settle allegations that it paid kickbacks to physicians to get them to purchase specialty drugs through Cardinal. According to the DOJ, the wholesale distributor gave doctors...
by Jordana Choucair | Feb 1, 2022 | Life Sciences
Pfizer and BioNTech are expected to soon ask the FDA to grant an emergency use authorization for their two-dose vaccine that can be administered to children under the age of five. According to sources familiar with the matter, the FDA urged the companies to submit...
by Jordana Choucair | Feb 1, 2022 | Life Sciences
The FDA granted Moderna’s COVID-19 vaccine full approval for use in people aged 18 and older. The vaccine, named Spikevax, is the second COVID-19 vaccine to receive full approval from the FDA, behind Pfizer’s Comirnaty vaccine. There’s no difference between the...
by Jordana Choucair | Feb 1, 2022 | Providers
Kaufman Hall’s latest monthly report found that hospitals performed better in 2021, although the industry is “still performing well below 2019” in regard to margins and volumes. According to the report, hospitals’ median change in operating margin for the full year of...
by Jordana Choucair | Feb 1, 2022 | Transition to Value
A new Lancet Commission on the Value of Death released a report calling for society to “rethink” how it approaches death. According to the authors, “How people die has changed dramatically over the past 60 years, from a family event with occasional medical...
Recent Comments